OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange


OriGene shRNA in recent publications
Enhancement of Autophagy during Lytic Replication by the Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Activator J. Virol., Aug 2010; 84: 7448 - 7458 [BECN1]

Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53 Mol. Cell. Biol., Aug 2010; 30: 3981 - 3993 [MYB ]

GPR103b Functions in the Peripheral Regulation of Adipogenesis Mol. Endocrinol., Aug 2010; 24: 1615 - 1625 []

Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis J. Biol. Chem., Aug 2010; 285: 24707 - 24716 [pRS]

ACAA2 (Locus ID 10449) Human shRNA

divider

To view the shRNA sequence, please register your email:
Email:
Register To View
Specifications Related Products Product Manual FAQs
Catalog No. Description Vector Price Delivery
TR315006 HuSH 29mer shRNA Constructs against ACAA2 (Locus ID = 10449)
4 constructs, 5 µg purified plasmid DNA per construct.
pRS $ 595 7-9 Days *
TR20003 HuSH shRNA Cloning vector (pRS) Included for free
TR30012 Non-effective 29-mer scrambled shRNA cassette in pRS Vector Included for free
Add to Shopping Cart
* Delivery time in business days.
* These shRNA constructs were designed to be effective against maximum number of transcriptional variants at this gene locus.

Also for ACAA2 (Locus ID 10449)
spacer
Register To View Sequence

Reference Data
RefSeq: NM_006111XM_166287XM_170628
Synonyms: DSAEC; FLJ35992; FLJ95265
Summary: The encoded protein catalyzes the last step of the mitochondrial fatty acid beta-oxidation spiral. Unlike most mitochondrial matrix proteins, it contains a non-cleavable amino-terminal targeting signal. [provided by RefSeq]. COMPLETENESS: complete on the 3' end.
Performance Guranteed:
OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

 

pattern
Copyright © 2010 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.